ALNY vs SKY · P/E 76, rev $1.29B vs P/E 20, rev $2.66B
Alnylam Pharmaceuticals Inc (ALNY) versus Skyline Corporation (SKY) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Skyline Corporation (SKY) is a residential construction company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SKY revenue for 2026-03-28 was $2.66B. Net income was $206.9M. Revenue was up 7.3% from 2025-03-29 to 2026-03-28. SKY currently screens at market cap $3.83B and trailing P/E 19.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SKY currently screens at market cap $3.83B and trailing P/E 19.6.
Not investment advice. Open the ALNY and SKY stock pages for the full models.
Not investment advice.